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the original work isIntroduction: Although prevention of mother-to-child HIV transmission (PMTCT)
programs are widely implemented, many children do not benefit from them because
of loss to follow-up (LTFU). We conducted a systematic review to determine the
magnitude of infant/baby LTFU along the PMTCT cascade.
Methods: Eligible publications reported infant LTFU outcomes from standard care
PMTCT programs (not intervention studies) at any stage of the cascade. Literature
searches were conducted in Medline, Embase, Web of Knowledge, CINAHL
Plus, and Maternity and Infant Care. Extracted data included setting, methods of
follow-up, PMTCT regimens, and proportion and timing of LTFU. For programs in
sub-Saharan Africa, random-effects meta-analysis was done using Stata v10.
Because of heterogeneity, predictive intervals (PrIs; approximate 95% confidence
intervals of a future study based on extent of observed heterogeneity) were
computed.
Results: A total of 826 papers were identified; 25 publications were eligible. Studies
were published from 2001 to 2012 and were mostly from sub-Saharan Africa
(three were from India, one from UK and one from Ireland). There was extensive
heterogeneity in findings. Eight studies reported on LTFU of pregnant HIV-positive
women between antenatal care (ANC) registration and delivery, which ranged from
10.9 to 68.1%, pooled proportion 49.08% [95% confidence interval (CI) 39.6–60.9%],
and PrI 22.0–100%. Fourteen studies reported LTFU of infants within 3 months of
delivery, range 4.8–75%, pooled proportion 33.9% (27.6–41.5), and PrI 15.4–74.2.
Children were also lost after HIV testing; this was reported in five studies, pooled
estimate 45.5% (35.9–57.6), PrI 18.7–100%. Programs that actively tracked defaulters
had better retention outcomes.
Conclusion: There is unacceptable infant LTFU from PMTCT programs. Countries
should incorporate defaulter-tracking as standard to improve retention.
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There have been significant developments in knowledge
of interventions that can save lives of HIV-exposed
infants. Current WHO guidelines recommend HIV
testing of HIV-exposed infants at 4–6 weeks [1]
postnatally (early infant diagnosis, EID), and immediate
antiretroviral therapy (ART) initiation for those testing
positive. As early cessation of breastfeeding is associated
with poor health outcomes for HIV-exposed babies
[2–6], current guidelines support continued breastfeed-
ing in conjunction with extended infant prophylaxis with
nevirapine (WHO option A) [7], and re-testing of the
exposed baby at least 6 weeks after cessation of
breastfeeding [1]. Also, included within the guidelines
are recommendations for infant feeding in the context of
HIV [5], which stress that carers need to be educated
about the importance of exclusive breastfeeding in the
first 6 months of life. All these guidelines necessitate
continued follow-up of exposed babies to ensure their full
participation in the postnatal care cascade. Yet despite
advances in knowledge of effective interventions to save
lives of HIV-exposed infants, many infants do not access
the full package of services because of loss to follow-up
(LTFU) [8–11]. There is literature on LTFU of infants in
research settings, and also in real-life program settings.We
conducted a systematic review in order to determine the
magnitude of LTFU of HIV-exposed infants from real-life
(nonresearch intervention) PMTCT programs, and to
describe program characteristics associated with lower
rates of infant LTFU in order to inform future program
and policy development.Methods
Publications were eligible for inclusion if they reported on
LTFU of HIV-exposed infants/children from usual care
programs rather than from research studies/programs.
Medline, Embase, Web of Knowledge, CINAHL Plus,
and Maternity and Infant Care were searched.
Search strategy
The research question was split into three components:
children/infants, HIV exposure, and retention/LTFU.
For each component, text and Medical Subject Heading
(MeSH) searches were performed. The text search terms
for the children/infants component were as follows:
Child OR infant OR newborn OR baby OR babies.
The terms for HIV exposure were as follows: ‘‘HIV
exposed or HIV positive adj3 mother’’ OR ‘‘HIV
infected adj3 mother’’ OR ‘‘born adj3 HIV positive
wom#n’’ OR ‘‘born adj3 HIV infected wom#n’’ OR
PMTCT OR ‘‘prevention of mother to child trans-
mission’’. The terms for retention/LTFUwere as follows:
‘‘continuum of care’’ OR retention OR attrition OR
‘‘patient dropout’’ OR ‘‘los? to follow up’’ OR LTFUpyright © Lippincott Williams & Wilkins. UnauthoOR LFU OR ‘‘lost follow up’’ OR ‘‘Early infant
diagnosis’’ OR EID. Results from the three components
were narrowed to include only publications that featured
all three components. The search process was iterative:
pilot searches were conducted and checks for suitability of
search terms were conducted. Refinements were made
and the final search was conducted on 06 August 2012.
Selection of eligible papers and additional
searches
Results from database searches were combined and
duplicates removed. Each title and abstract was reviewed
to determine eligibility. A paper was rejected if it was
obvious from title/abstract review that it was ineligible.
When it was less clear, the full paper was reviewed. Next,
reference and citation lists of eligible papers and those of
other relevant papers were downloaded from the Web
of Knowledge database and reviewed for eligibility.
Eligibility review was conducted by E.L.S. Each eligible
publication was assessed for quality using a checklist that
was adapted from the UK National Institute for Health
and Clinical Excellence (NICE) methodology checklist
for cohort studies [12]. For each study, an overall
subjective judgment was made on how well the study
findings were protected against bias and confounding.
Data extraction and synthesis
Information captured using a data collection form
included place of study, setting (urban or rural), program
years, testing strategy (whether opt-in or opt-out),
schedule and methods of infant follow-up, prevention
of mother-to-child HIV transmission (PMTCT) regi-
mens offered, whether replacement feeding was offered
for free during the years studied, and magnitude and
timing of LTFU.
Study findings were split into categories relating to timing
of LTFU as follows: LTFU of pregnant HIV-positive
women between ANC registration and delivery; LTFU of
HIV-exposed infants by age 3 months; LTFU of HIV-
exposed infants by 12 months of age; LTFU by 18months
of age, and LTFU of infants after determination of HIV
status. For studies in sub-Saharan Africa, random-effects
meta-analysis using the method of DerSimonian and
Laird [13] was conducted for each category/timing of
LTFU using Stata v10. Data values were log-transformed
before analysis and the results back-transformed to
percentages. There was extensive heterogeneity of study
findings; therefore, predictive intervals (PrIs; approximate
95% confidence intervals of a future study based on the
observed heterogeneity) were computed as recom-
mended good practice in the presence of significant
heterogeneity [14]. To investigate the sources of
heterogeneity, random-effects meta-regression analysis
[15] was done with each of the extracted variables that
were suspected to explain the heterogeneity: setting
(urban/rural); model for offering HIV testing; mother’s
PMTCT regimen (single dose nevirapine vs. morerized reproduction of this article is prohibited.
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was offered for free during program years.Results
A total of 826 papers from database and reference/citation
lists were reviewed (Fig. 1a). Eighteen eligible papers
were identified from database searches, and an additional
seven were identified after reviewing reference and
citation lists, bringing the total of eligible papers from
which data were extracted to 25, (Fig. 1b).
Description of eligible papers
Twenty studies were from sub-Saharan Africa: four
[16–19] from South Africa, two each from Kenya
[20,21], Nigeria [22,23], Mozambique [24,25], Malawi
[26,27], Uganda [28,29], and Ethiopia [30,31], one from
each of the following: Zimbabwe [32], Cameroon [33],
Angola [34], and Tanzania [35]. Three studies were from
India [36–38], and one each from United Kingdom and
Ireland [39,40]. All were viewed to be either of good
(17 studies) or fair (eight studies) quality [12]; as a result,
they were all included in result syntheses as applicable.
Seven studies were set in rural areas, 14 in urban areas,
and three included both urban and rural sites. The
PMTCT regimen provided for mothers during the
study period was single dose nevirapine for nine
studies and was more intensive (dual/triple therapy) for
13 studies (Table 1).
Loss to follow-up of HIV-positive pregnant
women
Eight studies reported on LTFU of HIV-positive pregnant
women between ANC registration and delivery. Six of
these were in sub-Saharan Africa and two from India. The
percentage LTFU in these eight studies ranged from
10.9 to 68.1%. The lowest proportion of 10.9% was
reported in Maharashtra, India, a private sector PMTCT
program in which women who missed their appoint-
ments were followed up by letter, phone calls, or home
visits [37]. The pooled estimate of LTFU among the six
sub-Saharan African countries was 49.08% (95% confi-
dence interval 39.6–60.9%; PrI 22.0–100% (Fig. 2)].
On meta-regression analysis, only the type of PMTCT
regimen (whether single dose nevirapine or more
intensive regimens) was also associated with LTFU;
there was higher LTFU in the sites that offered single
dose nevirapine than in those that offered more
intensive regimens (P¼ 0.006). However, this did not
account for all heterogeneity; there was 92% residual
heterogeneity.
Loss to follow-up of infants by age 3 months
Fourteen studies reported on LTFU of infants soon after
delivery; the infants typically did not return for HIVCopyright © Lippincott Williams & Wilkins. Unauttesting at 6 weeks. About half of the studies reported this
as LTFU at 6 weeks, but some studies reported loss by
8 weeks, or 3 months. In order to synthesize data from all
studies that reported LTFU soon after delivery, a cut-off
point of 3 months was reported. The percentage LTFU by
age 3 months in the 14 studies ranged from 4.1 to 75.0%.
The LTFU percentages in the studies in Ireland, UK, and
India were 4.1, 26.0, and 19.6, respectively. The pooled
estimate among 11 sub-Saharan African countries was
33.9% (27.6–41.5), PrI 15.4–74.2 (Fig. 3).
The lowest LTFU percentages were reported in Ireland
and Malawi. In Ireland, there was a system for follow-up
of HIV-exposed infants, which was enhanced by having a
single center for the coordination of care of HIV-exposed
infants. However, although the study in Malawi [26]
reported low LTFU rates at 6 weeks, by the 6-month
postnatal visit 41% of infants had been lost; the babies
were initiated on cotrimoxazole prophylaxis, but were
lost from further evaluation. In that study all PMTCT
services were centrally provided at the hospital during
the reported period. This is one example in which
centralization of PMTCT services may not have worked
well: authors reported that women may have increasingly
found it more difficult to come back to the hospital
because of long distances in an area where there was no
public transport (women had to either walk or use
bicycles) and would, therefore, have benefited from
decentralized services at local clinics. The program in
Cameroon [33] tracked clients using mobile phones; 90%
of clients had mobile phones. This tracking may have
improved their LTFU rates as they had comparatively
lower LTFU rates than other sites of 17%. There was also
good tracking of defaulters in the UK study in London
[39], which reported a LTFU of 26%. Of note, the
majority of infants lost to follow-up in that program were
born to African mothers, 89% compared with 71% of
those who completed follow-up.
Both Mozambican studies reported LTFU rates of about
75%, in a setting in which there was lack of confidential
counseling for women in crowded postnatal wards. The
authors reported that this environment may have resulted
in HIV-positive women feeling uncomfortable, thereby
lessening their chances of returning to the hospital for
the baby’s EID. In addition, authors reported that the
provision of EID services occurred in a different building
from the onewhere referral was made possibly resulting in
women getting lost between referral and follow-up.
Related to this, in one of the studies from Ethiopia [30]
some infants who had defaulted from EID had been to a
healthcare center for pentavalent vaccination at 6 weeks:
86% of infants were brought for pentavalent vaccine
compared with 52% for EID.
In meta-regression analysis, none of the variables
extracted from the studies explained the heterogeneity
in LTFU findings by age 3 months.horized reproduction of this article is prohibited.
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Total= 353
papers
Combining and
removing duplicates
Combining and
removing duplicates
Medline 131
papers
Embase 140
papers
Maternity &
infant care 33
papers
Web of
knowledge 141
papers
CINAHL plus 22
papers
Total= 826
papers reviewed
Reference/
citation lists 720
papers
(a)
220 papers deemed ineligible (or full text not available, 2 cases)
after title and abstract search
9 papers were not in English
* 4 French
* 2 Polish
* 1 Spanish
* 1 Italian
* 1 Chinese
22 studies did not longitudinally follow-up HIV exposed babies
50 papers were not reporting on routine/standard care but were
intervention studies
31 papers did not report on retention/loss to follow-up of HIV
exposed infants
3 eligible papers excluded as they were presenting data from
the same already included studies
Review of reference and citation lists of eligible papers and other
relevant papers
*7 more eligible papers identified
353 papers from database
searches
124 full papers reviewed
18 eligible papers
from database searches
25 eligible papers from
which data were extracted
(b)
Fig. 1. Literature search results and selection of eligible papers. (a) Results of literature searches. (b) Selection of eligible
papers.
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Fig. 3. Loss to follow-up of infants by age 3 months. CI, confidence interval; LTFU, loss to follow-up.
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Two studies (both from South Africa) reported on LTFU
of infants after 12 months. The studies reported losses of
85.1 and 50.2%, respectively. Both programs offered
single dose nevirapine.
Five programs, three of which offered single dose
nevirapine, reported on LTFU of infants by 18 months.
Twowere from India, with LTFU percentages of 37.9 and
29, and one each from Uganda (53.4%), Kenya (66.1%),
and Nigeria (20.8%).
Loss to follow-up of infants after HIV testing
Five studies (all from Sub-Saharan Africa) reported on
LTFU of infants following HIV testing, mostly EID by
PCR: infants were lost during the recommended follow-
up period after receipt of HIV results at about 45 days
(one study) [31], did not enrol into ART programs after
testing HIV positive in the EID program (one study) [22],
or did not return to collect HIV test results after EID (two
studies) [21,35]. The percentage LTFU after testing
ranged from 30.5 to 68.0%, pooled estimate, 45.5%
(35.9–57.6), and PrI 18.7–100%.
Again the benefit of active follow-up of defaulters was
apparent in the study in Tanzania [35], where the program
actively tracked HIV-positive infants who had not
returned to collect results. As a result, a lower percentage
LTFU of 32% among HIV-positive infants was observed
compared with 48% among the HIV-negative infants.Discussion
This systematic review revealed that there is an
unacceptable LTFU of HIV-exposed infants at several
points in the PMTCT care cascade in the programs
reported here. There was significant heterogeneity in the
study findings; pooled estimates were reported together
with PrIs to indicate the uncertainty in the estimates.
An estimated 49% of HIV-positive pregnant women in
Sub-Saharan Africa are lost between ANC registration
and delivery, whereas about 34% of infants are lost to
follow-up by 3 months. A further 45% of infants are lost
after HIV testing.
Of importance, the retention in a program is not
necessarily equivalent to retention in the healthcare
system; those women who have self-transferred out of a
program to another facility should not be regarded as lost
to follow-up. In this review, a third of programs either
actively sought but did not find evidence of women self-
transferring to other neighboring health sites or provided
the only PMTCT services in the communities in which
they operated. Four studies [16,24,25,39] acknowledged
the possibility of migration being misclassified as LTFUpyright © Lippincott Williams & Wilkins. Unauthoand the rest of the studies did not discuss this kind
of LTFU.
If a woman is LTFU before delivery, she may not take her
intrapartum antiretroviral prophylaxis and her baby is
unlikely to be initiated on the necessary prophylaxis after
delivery, and may not be registered for regular follow-up
in the PMTCT program. For the mother, LTFU can
result in delayed evaluation for disease progression and
initiation of life-saving ART. In this systematic review, we
found that programs that had an effective system for
tracking defaulters had better retention outcomes
suggesting that programmers should consider incorpor-
ating interventions to actively track women who have
missed their appointments. It is important that tracking
methods be appropriate for the setting. For example, the
program in Uganda [29] had a high LTFU of 40% despite
having a telephone tracking system because only 50%
of clients had telephone contacts. Tracking requires
resources, and depending on the setting andmethods used
can be expensive. Clearly, data on the relative costs and
benefits of introducing such follow-up activities are
required. There are other interventions that have been
found to improve retention, for example, provision of
confidential counseling space postpartum and direct
accompaniment of mothers to the centers where
continued care will be accessed from [24,41]. However,
some have not been assessed as part of routine care, so the
extent to which they would translate is unclear. Our
search strategy was not designed to find all interventions
that improve retention; we described nonresearch
interventions that were found to be effective in programs
that reported infant LTFU.
Of importance is the observation that even with active
tracking of defaulters, there are still unacceptably high
levels of LTFU along the PMTCT cascade, suggesting
that other barriers need to be overcome. Qualitative
studies have found that the following factors affect uptake
of PMTCT services: fear of involuntary disclosure of HIV
status, fear of stigma, disbelief of mother’s HIV result,
distance from health facility, fear of HIV-positive result for
the baby, cultural norms, cost of transport, and unfriendly
healthcare workers [42–49]. These challenges need to be
addressed so that programs offer acceptable, culturally
sensitive services that will attract all intended bene-
ficiaries.
That cultural norms play a significant part in retention
along the PMTCT cascade may be further evidenced by
the fact that the majority of infants whowere LTFU in the
program in London were born of African mothers; their
reasons for dropping out of care may be similar to the
barriers reported in African settings, where LTFU rates
are highest, but may also be due to concerns about
immigration status. There is evidence from Cote
d’Ivoire that economically disadvantaged women find
it more difficult to participate in PMTCT programs [50],rized reproduction of this article is prohibited.
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Fig. 4. Simulation of cumulative loss to follow-up of exposed infants along prevention of mother-to-child HIV transmission
cascade. EID, early infant diagnosis.suggesting the need for structural interventions to
promote retention.
Another program characteristic that was found to be
associated with LTFU was the type of antiretroviral
prophylaxis regimen offered; programs that offered single
dose nevirapine had higher rates of LTFU than those that
offered more intensive regimens. Single dose nevirapine
was used in earlier programs than dual/triple prophylaxis,
when programs were in the learning stages of how best to
provide PMTCT services. In addition, dual/triple
therapy necessitates more visits for prescription refills,
exposing the woman to more intensive support, which
may increase understanding of importance of PMTCT,
acceptance of HIV status, and client’s connectedness with
the healthcare system. The recent introduction of the
WHO Option Bþ program, in which all HIV-positive
pregnant/lactating women are given antiretroviral drugs,
which are continued for life may help increase retention
rates. Results from the Malawian Option Bþ program
indicate encouraging retention of 77% after 12 months of
the program [51].
WHO has recommended that integrating child health
services with PMTCTwill likely improve infant retention
in care [52]. In one of the Ethiopian programs reviewed
here [30], infants who had been lost from the PMTCT
program at 6 weeks had in fact been retained within the
child health program (as evidenced by receipt of
pentavalent vaccine at 6 weeks postnatally). Integration
of these two services may have reduced LTFU in the
PMTCT program. Importantly, integration should
ensure confidentiality is maintained; fear of involuntary
disclosure is a recurring theme in qualitative studies
exploring barriers to continued attendance of HIV-
related care visits. The two programs in Mozambique had
very high levels of LTFU of 75%, which the authors partly
attributed to lack of confidential counseling space.
If we simulate a cumulative LTFU cascade using data
obtained in this systematic review for sub-SaharanCopyright © Lippincott Williams & Wilkins. UnautAfrican countries, we will see that out of 100 HIV-
positive pregnant women who are enrolled into a
PMTCT program, only 19 infants are retained in care
following HIV testing, (Fig. 4).
The strength of this systematic review is that it synthesizes
real-life data from PMTCT programs. It provides a
picture of how routine services function. Although
studies were observational, they were generally of
reasonable quality and did not suffer from significant
bias in measurement of LTFU outcomes.
There was significant heterogeneity in the study findings,
with very wide PrIs. The main limitation of this review
was our inability to fully explore the causes of
heterogeneity. Another limitation of the review is that
it did not include gray literature, which is likely to
have had some reports from routine programs. This is a
trade-off that was made by preferring peer-reviewed
publications that were considered to have been more
rigorously reviewed.
In conclusion, there are unacceptably high levels of
LTFU of HIV-exposed infants at important points of the
PMTCT cascade. Effective tracking of defaulters reduces
LTFU; programmers should initiate effective interven-
tions for tracking defaulting clients. In addition, each
PMTCT site should investigate the patient-level factors
that limit adherence to visit schedules and address them in
a culturally sensitive and appropriate way.Acknowledgements
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